There were 511 press releases posted in the last 24 hours and 440,757 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
BridgeBio Shares Data on Serum TTR Increase When Switching Participants from Placebo and Tafamidis to Acoramidis in ATTRibute-CM and its Open-Label Extension

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image